Chinese consensus on early diagnosis of primary lung cancer (2014 version)-Reference-Cited by-同舟云学术

Chinese consensus on early diagnosis of primary lung cancer (2014 version)

Published:2015-09-01 Issue:S17 Volume:121 Page:3157-3164
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Hu Jie¹,Qian Gui-Sheng²,Bai Chun-Xue¹³,

Affiliation:

1. Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University; Shanghai Respiratory Research Institute; Shanghai China

2. Department of Pulmonary Medicine, Xinqiao Hospital of the Third Military Medical University; Chongqing China

3. State Key Laboratory of Respiratory Disease, Guangzhou; Guangzhou Medical University; Guangzhou China

Funder

The National Key Scientific and Technology Support Program: Collaborative Innovation of Clinical Research for Chronic Obstructive Pulmonary Disease and Lung Cancer

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29571/fullpdf

Reference21 articles.

1. Epidemiology: The dominant malignancy;Bender;Nature,2014

2. Emerging tabacco hazards in China:Retrospective proportional mortality study of one million deaths;BQ;BMJ.,1998

3. Three plus two diagnoses method for lung nodules;Bai;Int J Respir.,2013

4. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control;Jemal;J Natl Cancer Inst.,2008

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expert consensus on the evaluation and management of high-risk indeterminate pulmonary nodules;Clinical eHealth;2024-02

2. Development of an autoantibody panel for early detection of lung cancer in the Chinese population;Frontiers in Medicine;2023-11-27

3. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies;Biomedicine & Pharmacotherapy;2023-07

4. Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era;Medical Sciences;2023-01-04

5. Circulating CD45+EpCAM+ cells as a diagnostic marker for early-stage primary lung cancer;Frontiers in Medical Technology;2022-09-06